Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05209438 · ClinicalTrials.gov registry record · NA
Cereset Research for Caregivers
A NA study of Caregivers, sponsored by Wake Forest University Health Sciences.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05209438: Recruiting NA study of Caregivers, sponsored by Wake Forest University Health Sciences.
NCT05209438 is a NA study of Caregivers that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 20 participants, below the 99-participant average among 15 other Caregivers trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05209438, a NA study of Caregivers, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Caregivers experience high levels of prolonged stress that can lead to chronic problems with health, including increased risk of cardiovascular disease that is linked to autonomic dysregulation. Heart rate variability (HRV), measures of autonomic cardiovascular regulation, is decreased (worse) in caregivers. Autonomic function is linked to lateralization in the brain, and emerging neuromodulation methods that target lateralized signals in the brain, like Cereset (CR), may be able to improve heart rate variability. Therefore, this pilot study aims to test whether CR can improve HRV in caregivers of a person living with dementia experiencing stress, anxiety, or insomnia, as well as improve self-report measures of stress, sleep and caregiver burden.
Primary Outcome
BP measurements will be obtained using an automate oscillometric blood pressure device. Three samples will be obtained and the last two averaged to get the value that will be used as the reading for that visit.
Conditions Studied
Interventions
- DEVICE Cereset Research
Study Locations (1)
North Carolina
- Wake Forest University Health Sciences - Winston-Salem
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2022-06-16 |
| Est. Completion | 2026-07 |
| Phase | NA |
What NCT05209438 shows while recruiting
NCT05209438 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 99-participant average among 15 other Caregivers trials with a reported enrollment target (80% lower).
The record links to 1 condition, with Caregivers appearing as the primary indexed condition, and to 1 intervention - of which Cereset Research is the first listed.
NCT05209438 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05209438 about?
NCT05209438 is a clinical study titled "Cereset Research for Caregivers". Caregivers experience high levels of prolonged stress that can lead to chronic problems with health, including increased risk of cardiovascular disease that is linked to autonomic dysregulation. Heart rate variability (HRV), measures of autonomic cardiovascular regulation, is decreased (worse) in ca...
What is the current status of trial NCT05209438?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2022-06-16. Estimated completion is 2026-07.
What conditions does trial NCT05209438 study?
This clinical trial studies the following conditions: Caregivers.
What interventions are being tested in trial NCT05209438?
The interventions under investigation include: Cereset Research (DEVICE).
Who is sponsoring clinical trial NCT05209438?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05209438 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Caregivers
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05209438's enrollment target sits among peer trials
20 16th of 15 the lowest of 15 other Caregivers trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Caregivers trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Smartphone-based Cognitive Emotion Regulation Training for Unpaid Primary Caregivers of Persons With Alzheimer's Disease
RECRUITING · NA
-
Pilot Study of Hospital GamePlan4Care
RECRUITING · NA
-
A Nature-Based Virtual Reality (VR) Intervention in Family Caregivers of Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
RECRUITING · NA
-
Mind-body Resilience Program for Cardiac Arrest Survivors and Their Caregivers: Recovering Together After Cardiac Arrest
RECRUITING · NA
-
Supporting Care Partners' Well-Being With Artificial Intelligence (AI) Chatbots
RECRUITING · NA
-
A Study of an Anxiety Intervention for Latino/Latina/Hispanic Older Adults With Cancer and Their Caregivers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI